FDA — authorised 23 July 1993
- Application: BLA103471
- Marketing authorisation holder: BAYER HEALTHCARE PHARMS
- Status: supplemented
FDA authorised Betaseron on 23 July 1993
Yes. FDA authorised it on 23 July 1993; FDA has authorised it.
BAYER HEALTHCARE PHARMS holds the US marketing authorisation.